Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure
- PMID: 1552710
- DOI: 10.1038/ki.1992.51
Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure
Abstract
In hemodialysis patients with hyperkalemia, i.v. sodium bicarbonate has recently been found to be ineffective in lowering plasma potassium within one hour. In the present study the effect of a prolonged bicarbonate infusion on plasma potassium was investigated. Twelve patients with terminal renal failure who were on hemodialysis were infused i.v. with 8.4% sodium bicarbonate (4 mmol/min) for one hour and with 1.4% (0.5 mmol/min) for five hours (total amount 390 mmol). Plasma bicarbonate rose from 17.5 at baseline to 28.4 and 29.6 mmol/liter, and blood pH from 7.32 to 7.46 and 7.48 at one and six hours, respectively. Plasma potassium did not change significantly after one and two hours (6.04 at baseline, 5.91 and 5.77 mmol/liter, respectively). Only at four and six hours did a moderate decline to 5.44 (P less than 0.05) and to 5.30 (P less than 0.01) occur, of which approximately half was calculated to be due to ECF volume expansion. However, no change or a very moderate decrease was observed in three patients even after six hours (+0.19, -0.32, -0.33 mmol/liter). Five patients with higher baseline plasma potassium (6.15 to 8.15 mmol/liter) behaved like seven with lower levels (5.25 to 5.87 mmol/liter). Tented T-waves in the ECG of seven patients disappeared after one hour only in one patient. Plasma aldosterone, norepinephrine and epinephrine were normal to elevated before and tended to fall during i.v. bicarbonate. Plasma dopamine and insulin were in the normal range.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.Am J Med. 1988 Oct;85(4):507-12. doi: 10.1016/s0002-9343(88)80086-x. Am J Med. 1988. PMID: 3052050
-
Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.Nephron. 1996;72(3):476-82. doi: 10.1159/000188917. Nephron. 1996. PMID: 8852501
-
Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.Kidney Int. 1993 Jan;43(1):212-7. doi: 10.1038/ki.1993.34. Kidney Int. 1993. PMID: 8433561 Clinical Trial.
-
Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.Am J Kidney Dis. 1996 Oct;28(4):508-14. doi: 10.1016/s0272-6386(96)90460-6. Am J Kidney Dis. 1996. PMID: 8840939 Clinical Trial.
-
Hyperkalemia in end-stage renal disease: mechanisms and management.J Am Soc Nephrol. 1995 Oct;6(4):1134-42. doi: 10.1681/ASN.V641134. J Am Soc Nephrol. 1995. PMID: 8589279 Review.
Cited by
-
Current treatment and unmet needs of hyperkalaemia in the emergency department.Eur Heart J Suppl. 2019 Feb;21(Suppl A):A12-A19. doi: 10.1093/eurheartj/suy029. Epub 2019 Feb 26. Eur Heart J Suppl. 2019. PMID: 30837800 Free PMC article.
-
Insulin for the treatment of hyperkalemia: a double-edged sword?Clin Kidney J. 2014 Jun;7(3):239-41. doi: 10.1093/ckj/sfu049. Clin Kidney J. 2014. PMID: 25852882 Free PMC article. No abstract available.
-
Pathogenesis, diagnosis and management of hyperkalemia.Pediatr Nephrol. 2011 Mar;26(3):377-84. doi: 10.1007/s00467-010-1699-3. Epub 2010 Dec 22. Pediatr Nephrol. 2011. PMID: 21181208 Free PMC article. Review.
-
Plant-based diets to manage the risks and complications of chronic kidney disease.Nat Rev Nephrol. 2020 Sep;16(9):525-542. doi: 10.1038/s41581-020-0297-2. Epub 2020 Jun 11. Nat Rev Nephrol. 2020. PMID: 32528189 Review.
-
Hyperkalemia revisited.Tex Heart Inst J. 2006;33(1):40-7. Tex Heart Inst J. 2006. PMID: 16572868 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical